Real-World Insights Into Acute promyelocytic leukemia (APL) in Egypt in the Absence of Arsenic Trioxide (ATO): Clinical Characteristics, Outcomes and Risk Factors for Early Mortality: A Single Center Study | Synapse
March 3, 2026
Real-World Insights Into Acute promyelocytic leukemia (APL) in Egypt in the Absence of Arsenic Trioxide (ATO): Clinical Characteristics, Outcomes and Risk Factors for Early Mortality: A Single Center Study
Key Points
Acute promyelocytic leukemia patients showed significant early mortality rates, indicating the need for immediate interventions.
The study involved assessing clinical characteristics and outcomes among patients lacking arsenic trioxide treatment, revealing critical insights.
Observational analysis at a single center in Egypt highlighted various risk factors associated with early mortality.
These findings support the necessity for tailored treatment options in regions where arsenic trioxide is unavailable.